4:16 am - Sunday April 26, 2026

Drug pricing controls detrimental: Kiran Mazumdar-Shaw

Jul 16, 2014 1742 Viewed manishchowhan Add Source Preference

Kiran Mazumdar-Shaw, CMD of Biocon, tells NDTV that the NPPA’s decision to add more drugs under price control will have a detrimental impact on the industry and the pharmaceutical sector has been completely overlooked in this Budget.
Watch more videos: http://www.ndtv.com/video

Don't miss the stories followIndiaVision Social and Lifestyle and let's be smart!
prev-next.jpg

Auto sector beginning to see a turnaround: Pawan Goenka

prev-next.jpg

Drug pricing controls detrimental: Kiran Mazumdar-Shaw

Related posts